23andMe's co-founder and former chief executive, Anne Wojcicki, looks set to regain control of the business after emerging ...

Anne Wojcicki, former chief executive of 23andMe, won a bid to acquire the genetic testing company she founded in a second ...

De Meo plans to pursue challenges outside the automotive industry after five years leading the carmaker, with one report suggesting he is to become the new boss of Kering. Santos Gets $18.72 Billion ...

23andMe struck a deal last month with Regeneron Pharmaceuticals Inc., but Wojcicki complained about the bidding process, ...

Anne Wojcicki won a bid to purchase the genetic testing platform through her nonprofit TTAM Research Institute. The $305M deal was part of a bankruptcy auction, beating out offers from Regeneron ...

The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.

Several states have joined a lawsuit against 23andme. They say bankruptcy shouldn't allow the genetic testing company to sell ...

Welcome to the future, folks—where AI is regulated, genetic testing companies have more plot twists than a soap opera, and ...

Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...

A.I. may push ad creatives from producing to consulting. At Cannes, Monks, a marketing technology agency, will showcase a new ...

Ah, New York. The city that never sleeps is now the city that never lets AI sleep soundly, either. In a world where AI is ...

Anne Wojcicki, the co-founder and former CEO of 23andMe, will purchase the bankrupt company’s assets for $305 million, the genetic testing company said Friday. Regeneron Pharmaceuticals had agreed to ...